Navigation Links
Final Patient Completes Treatment In Boehringer Ingelheim's RE-LY(R) Study, The Largest Atrial Fibrillation Outcomes Trial To Date
Date:3/20/2009

RIDGEFIELD, Conn., March 20 /PRNewswire/ -- Boehringer Ingelheim today announced that the last patient has completed treatment in the Phase III Randomized Evaluation of Long term Anticoagulant therapy (RE-LY(R)) study. This study compared the long-term efficacy and safety of the oral direct thrombin inhibitor dabigatran etexilate with the current standard therapy, warfarin (target international normalized ratio, INR, 2-3) for the prevention of stroke and non-CNS systemic embolism in patients with atrial fibrillation (AF). Dabigatran etexilate is an oral anticoagulant in Phase III development for stroke prevention in AF, as well as several other therapeutic areas. Dabigatran etexilate is not approved by the FDA. RE-LY(R) is the largest AF stroke prevention trial to date. The study enrolled 18,113 patients in more than 900 centers in 44 countries worldwide between December 2005 and December 2007. Data will now be analyzed and results are expected to be presented later this year at the European Society of Cardiology (ESC) Congress, taking place in Barcelona, Spain, from August 29th until September 2nd.

"We are delighted with the completion of treatment in the RE-LY study as it marks an important milestone in the ongoing development of dabigatran etexilate," said Paul Reilly, clinical program director, Boehringer Ingelheim. "We are grateful to the patients and investigators who participated in the study and look forward to further evaluating the safety and efficacy of dabigatran through the analysis of the data."

Atrial fibrillation affects more than 2.2 million Americans, making it the most common heart rhythm disorder in the U.S.(1) People with AF are at increased risk for forming blood clots in their hearts(2) which can raise their risk of stroke five-fold.(3) However, clinical studies show that up to 60 percent of AF related strokes can be prevented with appropriate anticoagulant therapy.(4) Vitamin K antagonists are the c
'/>"/>

SOURCE Boehringer Ingelheim
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Photos: Eight Finalists Lose 685 Pounds and Gain $800,000
2. Clinical Data from Plastic Surgeon in New Jersey Helped in Final Determination of 2008's Top Plastic Surgery Procedures
3. USPTO Issues Notice of Final Determination for Patent Term Extension for NAMENDA(R)
4. Ranbaxy Secures Final FDA Approval for Quinapril Hydrochloride + Hydrochlorothiazide Tablets
5. Nuvos High Throughput Experimentation Platform Selected as 2009 Edison Award Finalist
6. EMPLOYER SURVEY - Final Opportunity to Participate in the UBA Employer Benefits Perspective Survey
7. Final Economic Stimulus Bill Permits Americans Personal Health Information to Be Sold for Research and Public Health Purposes WITHOUT Patients Consent
8. The NBA Teams up With Body By Milk to Challenge Teenagers to Get Fit By Finals
9. OmniPod(R) Insulin Management System Selected as a Finalist for the 2009 Edison Best New Product Awards(TM)
10. Samplify Systems SAM1600 Family of Analog/Digital Converters Named Finalist in EDN Magazines 19th Annual Innovation Awards
11. Final House Vote on SCHIP Delivers Peace of Mind to Americas Families
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/21/2015)... CA (PRWEB) April 21, 2015 The ... at the beautiful Governor’s Academy prep school in Byfield, ... July 10-12, 2015, for boys entering grades 6-12. , ... and supplement the players’ fall coaching. , ... athletes. Not only are these the most unsung positions ...
(Date:4/21/2015)... The Science Museum of Virginia welcomes theoretical ... its Lunch Break Science program. On Wednesday, April 29, Dr. ... guests from the subatomic world of quantum mechanics to astronomical ... members of the community to grab lunch and take a ... will delve into the nucleus and dissect the complex world ...
(Date:4/21/2015)... Hills, CA (PRWEB) April 21, 2015 Dr. ... has just released an interesting infographic that takes a close ... millennials. , The new infographic, which appears on both Dr. ... The Rise of Plastic Surgery in the Age of the ... surgery in Beverly Hills to a variety of A-list ...
(Date:4/21/2015)... (PRWEB) April 21, 2015 Renewable energy, ... a few of the Earth Day topics USM ... and national leaders debate the affect of climate change ... variety of subject matter touching on the environmental concerns ... segments will delve into sustainable lifestyles, clean air options, ...
(Date:4/21/2015)... Freeslate, Inc ., the leading provider ... that the Centre for Catalysis Research and Innovation ... a Freeslate Core Module 3 (CM3) Reaction Screening ... to accelerate current research programs. The systems will be ... be available to academic users and industrial collaborators/ partners ...
Breaking Medicine News(10 mins):Health News:US Sports Camps and The Northeast Football Clinic Announce 2015 Lineman/Linebacker Clinic Schedule 2Health News:Quarks and Forks at the Science Museum of Virginia 2Health News:Beverly Hills Plastic Surgery Expert Dr. Zain Kadri Releases Thought-Provoking New Infographic 2Health News:USM Studios’ Programming Focuses on the Environment 2Health News:University of Ottawa Selects Freeslate Reaction Screening System to Support High-Throughput Research at the Centre for Catalysis Research and Innovation 2Health News:University of Ottawa Selects Freeslate Reaction Screening System to Support High-Throughput Research at the Centre for Catalysis Research and Innovation 3
... , , , ... (Nasdaq: HTWR ) (ASX: HIN) announced today the completion ... stock in a private placement in the United States and Australia ... a purchase price of US$22.00 per share resulting in gross proceeds ...
... pose dangers, experts say , MONDAY, Aug. 17 (HealthDay News) ... amounts of indoor ozone, then "spit" it out in the ... lungs, new research suggests. , "They are saying that compounds ... irritation to the skin," explained one expert, Rajat Sethi, an ...
... two disorders , MONDAY, Aug. 17 (HealthDay News) -- Dr. ... commonly used to combat high blood pressure can help prevent ... But people in the know tend to listen carefully to ... University, because one of his ideas was crucial in the ...
... BEDFORD, Mass., Aug. 17 Insulet Corporation (Nasdaq: ... its OmniPod(R) Insulin Management System, today announced the appointment of ... created role, Mr. Devlin will lead the Company,s Sales and ... , "Peter brings a distinguished track record ...
... interaction, researchers prevent disease production , MONDAY, Aug. ... to block HIV infections in the lab with synthetic ... , In the study, researchers developed synthetic molecules that ... called gp41 to interact with proteins in host cells. ...
... monitored in those with head and neck malignancies, researchers ... levels of post-treatment pain in head and neck cancer ... U.S. researchers have found. , Their study included 339 ... of life at diagnosis and three, six, nine and ...
Cached Medicine News:Health News:HeartWare International, Inc. Closes US$60 Million Financing 2Health News:HeartWare International, Inc. Closes US$60 Million Financing 3Health News:Toxins May Form When Skin, Indoor Ozone Meet 2Health News:Toxins May Form When Skin, Indoor Ozone Meet 3Health News:Blood Pressure Drug Might Work Against MS 2Health News:Blood Pressure Drug Might Work Against MS 3Health News:Insulet Appoints Peter J. Devlin as Chief Commercial Officer 2Health News:Synthetic Protein Thwarts HIV Infection in Lab 2Health News:Pain Level May Predict Survival in Certain Cancer Patients 2
(Date:4/20/2015)... -- This report analyzes the worldwide markets for Breast Pumps ... Pumps, and Powered Breast Pumps. The report provides separate comprehensive ... Japan , Europe , ... and forecasts are provided for the period 2014 through 2020. ... Market data and analytics are derived from primary and secondary ...
(Date:4/20/2015)... 2015 Actavis plc (NYSE: ACT ... , Chief Communications Officer, will retire from Actavis ... conjunction with Mayr,s retirement, Alex Kelly , ... Chief Communications Officer, effective immediately. Prior to joining ... President, Chief Communications Officer, Public Affairs and Investor ...
(Date:4/20/2015)... , April 20, 2015 This report analyzes ... in US$ Million. The report provides separate comprehensive analytics ... Europe , and Rest of World. Annual ... through 2020. Also, a seven-year historic analysis is provided ... from primary and secondary research. Company profiles are primarily ...
Breaking Medicine Technology:World Breast Pumps Industry 2World Breast Pumps Industry 3World Breast Pumps Industry 4World Breast Pumps Industry 5World Breast Pumps Industry 6World Breast Pumps Industry 7World Breast Pumps Industry 8World Breast Pumps Industry 9World Breast Pumps Industry 10World Breast Pumps Industry 11World Breast Pumps Industry 12World Breast Pumps Industry 13World Breast Pumps Industry 14Actavis Announces Retirement of Charles M. Mayr 2Actavis Announces Retirement of Charles M. Mayr 3World Medical Equipment Rental and Leasing Industry 2World Medical Equipment Rental and Leasing Industry 3World Medical Equipment Rental and Leasing Industry 4World Medical Equipment Rental and Leasing Industry 5World Medical Equipment Rental and Leasing Industry 6World Medical Equipment Rental and Leasing Industry 7
... of Minnesota is opening a new helipad on its Minneapolis ... they need it most. The new helipad ... minutes, by eliminating the need to move patients from the ... a distance of about a half a mile. ...
... 2011 Abaxis, Inc. (NasdaqGS: ABAX), a medical products ... Kenneth Aron, Chief Technology Officer, will present at the ... Investor Forum on Thursday, November 10, 2011 at 1:20 ... Grand Hyatt New York Hotel in New York City. ...
Cached Medicine Technology:Children's Hospitals and Clinics of Minnesota Opens New Helipad on its Minneapolis Campus 2Abaxis, Inc. to Present at Sidoti & Company's New York II Emerging Growth Institutional Investor Forum 2
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: